Start
Completion

Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

RecruitingRegisteredCTG

Single-group pilot interventional study (n=7) evaluating IM ketamine administered weekly for three weeks combined with brief motivational enhancement therapy for tobacco use disorder.

Details

The purpose of this study is to examine whether ketamine improves treatment outcomes for tobacco use disorder when delivered with brief motivational enhancement therapy. Participants receive IM ketamine once weekly for three weeks paired with a brief motivational enhancement therapy session.

Assessments include questionnaires and saliva samples at each visit; there are two follow-up visits and overall participation lasts approximately eight weeks.

Topics:Tobacco/Nicotine Use Disorder (TUD)

Registry

Registry linkNCT05796791